Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content
Global Health

Research & Reports

Global Immunization Division Research Program 2016-2013

Beginning in fiscal year 2011, the Global Immunization Division established a competitive “request for proposals” to support vaccine research projects that address vaccine-preventable disease elimination or eradication. ¬The main goals of this initiative include building a stronger research program and establishing new or strengthening current collaborations with international research partners.

 

This report provides a summary of accomplishments from the first three years of this research initiative in the context of the Global Vaccine Action Plan recommended action(s) and a listing of the countries and partnerships funded in research projects.

Global Immunization Division Research

Cholera

2015

  • Phares CR, Date K, Travers P, Déglise C, Wongjindanon N, Ortega L, Bhuket PR. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand. Vaccine. 2015 Nov 5. pii: S0264-410X(15)01568-6. doi: 10.1016/j.vaccine.2015.10.112. [Epub ahead of print] PubMed PMID: 26549363.
  • Tohme RA, François J, Wannemuehler K, Iyengar P, Dismer A, Adrien P, Hyde TB, Marston BJ, Date K, Mintz E, Katz MA. Oral Cholera Vaccine Coverage, Barriers to Vaccination, and Adverse Events following Vaccination, Haiti, 2013(1). Emerg Infect Dis. 2015 Jun;21(6):984-91. doi: 10.3201/eid2106.141797. PubMed PMID: 25988350; PubMed Central PMCID: PMC4451924.

Ebola

2014

  • Nyenswah TG, Fahnbulleh M, Ketah F, Massaquoi M, Nagbe T, Bawo L, Falla JD, Kohar H, Gasasira A, Nabeth P, Popowitz H, Yett S, Hurum L, Sailly L, Gergonne B, Casey S, Espinosa B, McCoy A, Feldman H, Hensley L, Baily M, Pendarvis J, Fields B, Lo T, Qin J, Aberle-Grasse J, Lindblade K, Mott J, Boulanger L, Christie A, Wang SA, Mongomery J, Mahoney F.  Ebola epidemic – Liberia, March – October 2014.  MMWR 2014; 63(46):1082-1086.
  • Shuaib F, Gunnala R, Musa EO, Mahoney FJ, Oguntimehin O, Nguku PM, Nyanti SB, Knight N, Gwarzo NS, Idigbe O, Nasidi A, Vertefeuille JF; Centers for Disease Control and Prevention (CDC). Ebola virus disease outbreak - Nigeria, July-September 2014. MMWR Morb Mortal Wkly Rep. 2014 Oct 3; 63(39):867-72. PubMed PMID: 25275332.

Encephalitis

2015

  • Lopez AL, Aldaba JG, Roque VG Jr, Tandoc AO 3rd, Sy AK, Espino FE, DeQuiroz-Castro M, Jee Y, Ducusin MJ, Fox KK. Epidemiology of Japanese encephalitis in the Philippines: a systematic review. PLoS Negl Trop Dis. 2015 Mar 20;9(3):e0003630. doi: 10.1371/journal.pntd.0003630. eCollection 2015 Mar. PubMed PMID: 25794009; PubMed Central PMCID: PMC4367992.

2014

  • Hills S, Martin R, Marfin A, Fischer M. Control of Japanese encephalitis in Asia: the time is now. Expert Rev Anti Infect Ther. 2014 Aug; 12(8):901-4. doi: 10.1586/14787210.2014.929498. Epub 2014 Jun 13. PubMed PMID: 24927959.
  • Li Y, Yin Z, Shao Z, Li M, Liang X, Sandhu HS, Hadler SC, Li J, Sun Y, Li J, Zou W, Lin M, Zuo S, Mayer LW, Novak RT, Zhu B, Xu L, Luo H; Acute Meningitis and Encephalitis Syndrome Study Group. Population-based surveillance for bacterial meningitis in China, September 2006-December 2009. Emerg Infect Dis. 2014 Jan; 20(1):61-9. doi: 10.3201/eid2001.120375. PubMed PMID: 24377388; PubMed Central PMCID: PMC3884703.

Hepatitis B

2015

  • Khetsuriani N, Tishkova F, Jabirov S, Wannemuehler K, Kamili S, Pirova Z, Mosina L, Gavrilin E, Ursu P, Drobeniuc J. Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan. Vaccine. 2015 Jul 31;33(32):4019-24. doi: 10.1016/j.vaccine.2015.05.092. Epub 2015 Jun 10. PubMed PMID: 26072015.
  • Kitau R, Datta SS, Patel MK, Hennessey K, Wannemuehler K, Sui G, Lagani W. Hepatitis B surface antigen seroprevalence among children in Papua New Guinea, 2012-2013. Am J Trop Med Hyg. 2015 Mar;92(3):501-6. doi: 10.4269/ajtmh.14-0537. Epub 2015 Jan 12. PubMed PMID: 25582692; PubMed Central PMCID: PMC4350538.
  • Li X, Wiesen E, Diorditsa S, Toda K, Duong TH, Nguyen LH, Nguyen VC, Nguyen TH. Impact of Adverse Events Following Immunization in Viet Nam in 2013 on chronic hepatitis B infection. Vaccine. 2015 Jun 6. pii: S0264-410X(15)00740-9. doi: 10.1016/j.vaccine.2015.05.067. [Epub ahead of print] PubMed PMID: 26055296.

2014

  • Nguyen TH, Vu MH, Nguyen VC, Nguyen LH, Toda K, Nguyen TN, Dao S, Wannemuehler KA, Hennessey KA. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination. Vaccine. 2014 Jan 3; 32(2):217-22. doi: 0.1016/j.vaccine.2013.11.004. Epub 2013 Nov 24. PubMed PMID: 24284410.
  • Patel MK, Capeding RZ, Ducusin JU, de Quiroz Castro M, Garcia LC, Hennessey K. Findings from a hepatitis B birth dose assessment in health facilities in the Philippines: opportunities to engage the private sector. Vaccine. 2014 Sep 3;32(39):5140-4. doi: 10.1016/j.vaccine.2013.11.097. Epub 2013 Dec 19. PubMed PMID: 24361121.
  • Upreti SR, Gurung S, Patel M, Dixit SM, Krause LK, Shakya G, Wannemuehler K, Rajbhandari R, Bohara R, Schluter WW. Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal. Vaccine. 2014 Jul 23; 32(34):4304-9. doi: 10.1016/j.vaccine.2014.06.027. Epub 2014 Jun 18. PubMed PMID: 24951865.

HIV

2014

  • Wallace A, Kimambo S, Dafrossa L, Rusibamayila N, Rwebembera A, Songoro J, Arthur G, Luman E, Finkbeiner T, Goodson JL. Qualitative assessment of the integration of HIV services with infant routine immunization visits in Tanzania. J Acquir Immune Defic Syndr. 2014 May 1; 66(1):e8-e14. doi: 10.1097/QAI.0000000000000078. PubMed PMID: 24326602.

HPV

2015

  • Potter RC, Flagg EW, Datta SD, Saraiya M, Copeland G. Monitoring the impact of human papillomavirus vaccines on high-grade pre-invasive cervical lesions: designing a framework of linked immunization information system and cancer registry data in Michigan. Vaccine. 2015 Mar 10;33(11):1400-5. doi: 10.1016/j.vaccine.2014.12.063. Epub 2015 Jan 6. PubMed PMID: 25573038.
  • Raesima MM, Forhan SE, Voetsch AC, Hewitt S, Hariri S, Wang SA, Pelletier AR, Letebele M, Pheto T, Ramogola-Masire D, El-Halabi S. Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013. MMWR Morb Mortal Wkly Rep. 2015 Oct 16;64(40):1147-9. doi: 10.15585/mmwr.mm6440a5. PubMed PMID: 26468997.

2014

  • Friedman AL, Oruko KO, Habel MA, Ford J, Kinsey J, Odhiambo F, Phillips-Howard PA, Wang SA, Collins T, Laserson KF, Dunne EF. Preparing for human papillomavirus vaccine introduction in Kenya: implications from focus-group and interview discussions with caregivers and opinion leaders in Western Kenya. BMC Public Health. 2014 Aug 16; 14:855. doi: 10.1186/1471-2458-14-855. PubMed PMID: 25128911; PubMed Central PMCID: PMC4158067.
  • Levin A, Wang SA, Levin C, Tsu V, Hutubessy R. Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries. PLoS One. 2014 Jun 26; 9(6):e101114. doi: 10.1371/journal.pone.0101114. eCollection 2014. PubMed PMID: 24968002; PubMed Central PMCID: PMC4072768.

Influenza

2015

  • McAnerney JM, Treurnicht F, Walaza S, Cohen AL, Tempia S, Mtshali S, Buys A, Blumberg L, Cohen C. Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014. Influenza Other Respir Viruses. 2015 Jul;9(4):209-15. doi: 10.1111/irv.12314. PubMed PMID: 25865249; PubMed Central PMCID: PMC4474497.
  • McAnerney JM, Walaza S, Cohen AL, Tempia S, Buys A, Venter M, Blumberg L, Duque J, Cohen C. Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010-2013. Influenza Other Respir Viruses. 2015 May;9(3):143-50. doi: 10.1111/irv.12305. PubMed PMID: 25677874; PubMed Central PMCID: PMC4415698.

2014

  • Bratton KN, Wardle MT, Orenstein WA, Omer SB. Maternal Influenza Immunization and Birth Outcomes of Stillbirth and Spontaneous Abortion: A Systematic Review and Meta-analysis. Clin Infect Dis. 2014 Nov 18. pii: ciu915. [Epub ahead of print] Review. PubMed PMID: 25409473.

Malaria

2014

  • Comfort AB, van Dijk JH, Mharakurwa S, Stillman K, Johns B, Hathi P, Korde S, Craig AS, Nachbar N, Derriennic Y, Gabert R, Thuma PE. Association between malaria control and paediatric blood transfusions in rural Zambia: an interrupted time-series analysis. Malar J. 2014 Sep 26; 13:383. doi: 10.1186/1475-2875-13-383. PubMed PMID: 25261276; PubMed Central PMCID: PMC4190292.

Measles & Rubella

2015

  • Chen M, Zhang Y, Huang F, Wang H, Liu D, Li J, Rodewald L, Wu J, Deng Y, Xu W. Endemic and imported measles virus-associated outbreaks among adults, Beijing, China, 2013. Emerg Infect Dis. 2015 Mar;21(3):477-9. doi: 10.3201/eid2103.140646. PubMed PMID: 25695536; PubMed Central PMCID: PMC4344261.
  • Ducusin MJ, de Quiroz-Castro M, Roesel S, Garcia LC, Cecilio-Elfa D, Schluter WW, Goodson JL, Lam E. Using the World Health Organization Measles Programmatic Risk Assessment Tool for Monitoring of Supplemental Immunization Activities in the Philippines. Risk Anal. 2015 May 7. doi: 10.1111/risa.12404. [Epub ahead of print] PubMed PMID: 25950923.
  • Edens C, Collins ML, Goodson JL, Rota PA, Prausnitz MR. A microneedle patch containing measles vaccine is immunogenic in non-human primates. Vaccine. 2015 Sep 8;33(37):4712-8. doi: 10.1016/j.vaccine.2015.02.074. Epub 2015 Mar 12. PubMed PMID: 25770786; PubMed Central PMCID: PMC4554796.
  • Grant GB, Reef SE, Dabbagh A, Gacic-Dobo M, Strebel PM. Global Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination -2000-2014. MMWR Morb Mortal Wkly Rep. 2015 Sep 25;64(37):1052-5. doi:10.15585/mmwr.mm6437a5. PubMed PMID: 26401958.
  • Harris JB, Badiane O, Lam E, Nicholson J, Oumar Ba I, Diallo A, Fall A, Masresha BG, Goodson JL. Application of the World Health Organization Programmatic Assessment Tool for Risk of Measles Virus Transmission-Lessons Learned from a Measles Outbreak in Senegal. Risk Anal. 2015 Jun 11. doi: 10.1111/risa.12431. [Epub ahead of print] PubMed PMID: 26094651.
  • Hyde TB, Sato HK, Hao L, Flannery B, Zheng Q, Wannemuehler K, Ciccone FH, de Sousa Marques H, Weckx LY, Sáfadi MA, de Oliveira Moraes E, Pinhata MM, Olbrich Neto J, Bevilacqua MC, Tabith Junior A, Monteiro TA, Figueiredo CA, Andrus JK, Reef SE, Toscano CM, Castillo-Solorzano C, Icenogle JP; CRS Biomarker Study Group. Identification of Serologic Markers for School-Aged Children With Congenital Rubella Syndrome. J Infect Dis. 2015 Jul 1;212(1):57-66. doi: 10.1093/infdis/jiu604. Epub 2014 Oct 31. PubMed PMID: 25362195.
  • Lam E, Schluter WW, Masresha BG, Teleb N, Bravo-Alcántara P, Shefer A, Jankovic D, McFarland J, Elfakki E, Takashima Y, Perry RT, Dabbagh AJ, BanerjeeK, Strebel PM, Goodson JL. Development of a District-Level Programmatic Assessment Tool for Risk of Measles Virus Transmission. Risk Anal. 2015 May 15. doi: 10.1111/risa.12409. [Epub ahead of print] PubMed PMID: 25976980.
  • Kaiser R, Shibeshi ME, Chakauya JM, Dzeka E, Masresha BG, Daniel F, Shivute N. Surveys of measles vaccination coverage in eastern and southern Africa: a review of quality and methods used. Bull World Health Organ. 2015 May 1;93(5):314-9. doi: 10.2471/BLT.14.146050. Epub 2015 Mar 10. PubMed PMID: 26229202; PubMed Central PMCID: PMC4431515.
  • Ma C, Li F, Zheng X, Zhang H, Duan M, Yang Y, Hao L, Su Q, Rodewald L, Guo B, Xiao S, Wang H, Li L, Li J, Luo H, Gao L. Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013. BMC Infect Dis. 2015 Jan 22;15:23. doi: 10.1186/s12879-015-0752-z. PubMed PMID: 25608672; PubMed Central PMCID: PMC4307911.
  • Perry RT, Murray JS, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL. Progress Toward Regional Measles Elimination - Worldwide, 2000-2014. MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1246-51. doi: 10.15585/mmwr.6444a4. PubMed PMID: 26562349.
  • Scobie HM, Ilunga BK, Mulumba A, Shidi C, Coulibaly T, Obama R, Tamfum JJ, Simbu EP, Smit SB, Masresha B, Perry RT, Alleman MM, Kretsinger K, Goodson J. Antecedent causes of a measles resurgence in the Democratic Republic of theCongo. Pan Afr Med J. 2015 May 15;21:30. doi: 10.11604/pamj.2015.21.30.6335. eCollection 2015. PubMed PMID: 26401224; PubMed Central PMCID: PMC4561157.
  • Scobie HM, Ray A, Routray S, Bose A, Bahl S, Sosler S, Wannemuehler K, Kumar R, Haldar P, Anand A. Cluster survey evaluation of a measles vaccination campaign in Jharkhand, India, 2012. PLoS One. 2015 May 26;10(5):e0127105. doi: 10.1371/journal.pone.0127105. eCollection 2015. PubMed PMID: 26010084; PubMed Central PMCID: PMC4444104.
  • Takashima Y, Schluter WW, Mariano KM, Diorditsa S, de Quiroz Castro M, Ou AC, Ducusin MJ, Garcia LC, Elfa DC, Dabbagh A, Rota P, Goodson JL; Centers forDisease Control and Prevention (CDC). Progress toward measles elimination—Philippines, 1998-2014. MMWR Morb Mortal Wkly Rep. 2015 Apr 10;64(13):357-62. PubMed PMID: 25856257.
  • Thapa A, Khanal S, Sharapov U, Swezy V, Sedai T, Dabbagh A, Rota P, Goodson JL, McFarland J; Centers for Disease Control (CDC). Progress Toward Measles Elimination - South-East Asia Region, 2003-2013. MMWR Morb Mortal Wkly Rep. 2015 Jun 12;64(22):613-7. PubMed PMID: 26068565.
  • Thompson KM, Odahowski CL, Goodson JL, Reef SE, Perry RT. Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories. Risk Anal. 2015 Aug 6. doi: 10.1111/risa.12454. [Epub ahead of print] PubMed PMID: 26249328.
  • Toda K, Reef S, Tsuruoka M, Iijima M, Dang TH, Duong TH, Nguyen VC, Nguyen TH. Congenital rubella syndrome (CRS) in Vietnam 2011-2012--CRS epidemic after rubella epidemic in 2010-2011. Vaccine. 2015 Jul 17;33(31):3673-7. doi: 10.1016/j.vaccine.2015.06.035. Epub 2015 Jun 15. PubMed PMID: 26087296.
  • Zuo S, Cairns L, Hutin Y, Liang X, Tong Y, Zhu Q, Zhang D, Lee LA, Strebel P, Quick L. Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003-2009. Vaccine. 2015 Apr 21;33(17):2050-5. doi: 10.1016/j.vaccine.2015.02.078. Epub 2015 Mar 11. PubMed PMID: 25769207.

2014

  • Bose AS, Jafari H, Sosler S, Narula AP, Kulkarni VM, Ramamurty N, Oommen J, Jadi RS, Banpel RV, Henao-Restrepo AM. Case based measles surveillance in Pune: evidence to guide current and future measles control and elimination efforts in India. PLoS One. 2014 Oct 7; 9(10):e108786. doi: 10.1371/journal.pone.0108786. eCollection 2014. PubMed PMID: 25290339; PubMed Central PMCID: PMC4188558.
  • Fitter DL, Anselme R, Paluku G, Rey G, Flannery B, Tohme RA, Marston BJ, Griswold M, Boncy J, Vertefeuille JF. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012.  Vaccine 2014 17;32(1):69–73
  • Kaiser R. Emergency settings: be prepared to vaccinate persons aged 15 and over against measles. J Infect Dis. 2014 Dec 15; 210(12):1857-9. doi: 10.1093/infdis/jiu463. Epub 2014 Sep 5. PubMed PMID: 25193980.
  • Ma C, Hao L, Zhang Y, Su Q, Rodewald L, An Z, Yu W, Ma J, Wen N, Wang H, Liang X, Wang H, Yang W, Li L, Luo H. Monitoring progress towards the elimination of measles in China: an analysis of measles surveillance data. Bull World Health Organ. 2014 May 1; 92(5):340-7. doi: 10.2471/BLT.13.130195. Epub 2014 Feb 5. Erratum in: Bull World Health Organ. 2014 Aug 1; 92(8):620. PubMed PMID: 24839323; PubMed Central PMCID: PMC4007128.
  • Masresha BG, Kaiser R, Eshetu M, Katsande R, Luce R, Fall A, Dosseh AR, Naouri B, Byabamazima CR, Perry R, Dabbagh AJ, Strebel P, Kretsinger K, Goodson JL, Nshimirimana D; Centers for Disease Control and Prevention (CDC). Progress toward measles preelimination--African Region, 2011-2012. MMWR Morb Mortal Wkly Rep. 2014 Apr 4; 63(13):285-91. PubMed PMID: 24699765.
  • Murhekar MV, Ahmad M, Shukla H, Abhishek K, Perry RT, Bose AS, Shimpi R, Kumar A, Kaliaperumal K, Sethi R, Selvaraj V, Kamaraj P, Routray S, Das VN, Menabde N, Bahl S. Measles case fatality rate in Bihar, India, 2011–12. PLoS One. 2014 May 13; 9(5):e96668. doi: 10.1371/journal.pone.0096668. eCollection 2014. PubMed PMID: 24824641; PubMed Central PMCID: PMC4019661.
  • Navarro-Colorado C, Mahamud A, Burton A, Haskew C, Maina GK, Wagacha JB, Ahmed JA, Shetty S, Cookson S, Goodson JL, Schilperoord M, Spiegel P. Measles outbreak response among adolescent and adult Somali refugees displaced by famine in Kenya and Ethiopia, 2011. J Infect Dis. 2014 Dec 15; 210(12):1863-70. doi: 10.1093/infdis/jiu395. Epub 2014 Aug 12. PubMed PMID: 25117754.
  • Ogbuanu IU, Zeko S, Chu SY, Muroua C, Gerber S, De Wee R, Kretsinger K, Wannemuehler K, Gerndt K, Allies M, Sandhu HS, Goodson JL. Maternal, fetal, and neonatal outcomes associated with measles during pregnancy: Namibia, 2009-2010. Clin Infect Dis. 2014 Apr; 58(8):1086-92. doi: 10.1093/cid/ciu037. Epub 2014 Jan 22. PubMed PMID: 24457343.
  • Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL, Reef SE, Redd SB, Abernathy ES, Barskey AE, Hao L, McLean HQ, Rota JS, Bellini WJ, Seward JF. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr. 2014 Feb; 168(2):148-55. doi: 10.1001/jamapediatrics.2013.4342. PubMed PMID: 24311021.
  • Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL; Centers for Disease Control and Prevention (CDC). Progress toward regional measles elimination--worldwide, 2000-2013. MMWR Morb Mortal Wkly Rep. 2014 Nov 14; 63(45):1034-8. PubMed PMID: 25393223.
  • Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL; Centers for Disease Control and Prevention (CDC). Global control and regional elimination of measles, 2000–2012. MMWR Morb Mortal Wkly Rep. 2014 Feb 7; 63(5):103-7. PubMed PMID: 24500289.
  • Shibeshi ME, Masresha BG, Smit SB, Biellik RJ, Nicholson JL, Muitherero C, Shivute N, Walker O, Reggis K, Goodson JL. Measles resurgence in southern Africa: challenges to measles elimination. Vaccine. 2014 Apr 1; 32(16):1798-807. doi: 10.1016/j.vaccine.2014.01.089. Epub 2014 Feb 13. PubMed PMID: 24530936.
  • Teleb N, Lebo E, Ahmed H, Hossam AR, El Sayed el T, Dabbagh A, Strebel P, Rota P, Alexander J; Centers for Disease Control and Prevention (CDC). Progress toward measles elimination--Eastern Mediterranean Region, 2008-2012. MMWR Morb Mortal Wkly Rep. 2014 Jun 13; 63(23):511-5. PubMed PMID: 24918486.
  • Tohme RA, François J, Wannemuehler K, Magloire R, Danovaro-Holliday MC, Flannery B, Cavallaro KF, Fitter DL, Purcell N, Dismer A, Tappero JW, Vertefeuille JF, Hyde TB. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination. Trop Med Int Health. 2014 Sep;19(9):1105-15. doi: 10.1111/tmi.12335. Epub 2014 Jul 16. PubMed PMID: 25041586.
  • Wallace AS, Masresha BG, Grant G, Goodson JL, Birhane H, Abraham M, Endailalu TB, Letamo Y, Petu A, Vijayaraghavan M. Evaluation of economic costs of a measles outbreak and outbreak response activities in Keffa Zone, Ethiopia. Vaccine. 2014 Jul 31; 32(35):4505-14. doi: 10.1016/j.vaccine.2014.06.035. Epub 2014 Jun 18. PubMed PMID: 24951866.
  • Hyde TB, Sato HK, Hao L, Flannery B, Zheng Q, Wannemuehler K, Ciccone FH, de Sousa Marques H, Weckx LY, Sáfadi MA, de Oliveira Moraes E, Pinhata MM, Neto JO, Bevilacqua MC, Junior AT, Monteiro TA, Figueiredo CA, Andrus JK, Reef SE, Toscano CM, Castillo-Solorzano C, Icenogle JP; for the CRS Biomarker Study Group.Identification of Serologic Markers for School-Aged Children With Congenital Rubella Syndrome. J Infect Dis. 2014 Oct 31. pii: jiu604. [Epub ahead of print]PubMed PMID: 25362195.
  • Simons EA, Reef SE, Cooper LZ, Zimmerman L, Thompson KM. Systematic Review of the Manifestations of Congenital Rubella Syndrome in Infants and Characterization of Disability-Adjusted Life Years (DALYs). Risk Anal. 2014 Aug 12. doi: 10.1111/risa.12263. [Epub ahead of print] PubMed PMID: 25115193.
  • Thompson KM, Simons EA, Badizadegan K, Reef SE, Cooper LZ. Characterization of the Risks of Adverse Outcomes Following Rubella Infection in Pregnancy. Risk Anal. 2014 Aug 5. doi: 10.1111/risa.12264. [Epub ahead of print] PubMed PMID: 25100307.
  • Mao B, Chheng K, Wannemuehler K, Vynnycky E, Buth S, Soeung SC, Reef S, Weldon W, Quick L, Gregory CJ. Immunity to polio, measles and rubella in women of child-bearing age and estimated congenital rubella syndrome incidence, Cambodia, 2012. Epidemiol Infect. 2014 Nov 6:1–10. [Epub ahead of print] PubMed PMID: 25373419.

Meningococcal

2015

  • Diomandé FV, Djingarey MH, Daugla DM, Novak RT, Kristiansen PA, Collard JM, Gamougam K, Kandolo D, Mbakuliyemo N, Mayer L, Stuart J, Clark T, Tevi-Benissan C, Perea WA, Preziosi MP, Marc LaForce F, Caugant D, Messonnier N, Walker O, Greenwood B. Public Health Impact After the Introduction of PsA-TT: The First 4 Years. Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S467-72. doi: 10.1093/cid/civ499. PubMed PMID: 26553676
  • Diomandé FV, Yaméogo TM, Vannice KS, Preziosi MP, Viviani S, Ouandaogo CR, Keita M, Djingarey MH, Mbakuliyemo N, Akanmori BD, Sow SO, Zuber PL. Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010-2013. Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S459-66. doi: 10.1093/cid/civ599. PubMed PMID: 26553675; PubMed Central PMCID: PMC4639501.
  • Djingarey MH, Diomandé FV, Barry R, Kandolo D, Shirehwa F, Lingani C, Novak RT, Tevi-Benissan C, Perea W, Preziosi MP, LaForce FM. Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014. Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S434-41. doi: 10.1093/cid/civ551. PubMed PMID: 26553672; PubMed Central PMCID: PMC4639493.
  • Vannice KS, Keita M, Sow SO, Durbin AP, Omer SB, Moulton LH, Yaméogo TM, Zuber PL, Onwuchekwa U, Sacko M, Diomandé FV, Halsey NA. Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali. Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S493-500. doi: 10.1093/cid/civ497. PubMed PMID: 26553680; PubMed Central PMCID: PMC4639483.
  • Meyer SA, Kambou JL, Cohn A, Goodson JL, Flannery B, Medah I, Messonnier N, Novak R, Diomande F, Djingarey MH, Clark TA, Yameogo I, Fall A, Wannemuehler K. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization. Vaccine. 2015 Mar 17;33(12):1492-8. doi: 10.1016/j.vaccine.2015.01.043. Epub 2015 Jan 28. PubMed PMID: 25636915.

Pneumococcal

2015

  • Tempia S, Wolter N, Cohen C, Walaza S, von Mollendorf C, Cohen AL, Moyes J, de Gouveia L, Nzenze S, Treurnicht F, Venter M, Groome MJ, Madhi SA, von Gottberg A. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa. BMC Infect Dis. 2015 Oct 26;15(1):450. doi: 10.1186/s12879-015-1198-z. PubMed PMID: 26496761.
  • Ward, KF, Trent M, Hull BP, Quinn HE, Dey A, Menzies RI. Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings. BMC Health Serv Res. 2015 Mar 18;15:109. doi: 10.1186/s12913-015-0738-y. PubMed PMID: 25889782; PubMed Central PMCID: PMC4404082.

Polio Eradication

2015

  • Anand A, Zaman K, Estívariz CF, Yunus M, Gary HE, Weldon WC, Bari TI, Oberste MS, Wassilak SG, Luby SP, Heffelfinger JD, Pallansch MA. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial. Vaccine. 2015 Oct 14. pii: S0264-410X(15)01315-8. doi: 10.1016/j.vaccine.2015.09.039. [Epub ahead of print] PubMed PMID: 26476367.
  • Anand A, Zaman K, Estívariz CF, Yunus M, Gary HE, Weldon WC, Bari TI, Steven Oberste M, Wassilak SG, Luby SP, Heffelfinger JD, Pallansch MA. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial. Vaccine. 2015 Oct 23. pii: S0264-410X(15)01315-8. doi: 10.1016/j.vaccine.2015.09.039. [Epub ahead of print] PubMed PMID: 26476367.
  • Cavallaro KF, Sandhu HS, Hyde TB, Johnson BW, Fischer M, Mayer LW, Clark TA, Pallansch MA, Yin Z, Zuo S, Hadler SC, Diorditsa S, Hasan AS, Bose AS, Dietz V; AMES Study Group. Expansion of syndromic vaccine preventable disease surveillance to include bacterial meningitis and Japanese encephalitis: evaluation of adapting polio and measles laboratory networks in Bangladesh, China and India, 2007-2008. Vaccine. 2015 Feb 25;33(9):1168-75. doi: 10.1016/j.vaccine.2015.01.004. Epub 2015 Jan 15. PubMed PMID: 25597940.
  • Diop OM, Burns CC, Sutter RW, Wassilak SG, Kew OM; Centers for Disease Control and Prevention (CDC). Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015. MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):640-6. PubMed PMID: 26086635.
  • Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SG, Thompson KM. An economic analysis of poliovirus risk management policy options for 2013-2052. BMC Infect Dis. 2015 Sep 24;15(1):389. doi: 10.1186/s12879-015-1112-8. PubMed PMID: 26404632; PubMed Central PMCID: PMC4582932.
  • Duintjer Tebbens RJ, Pallansch MA, Wassilak SG, Cochi SL, Thompson KM. Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria. PLoS One. 2015 Jun 11;10(6):e0130123. doi: 10.1371/journal.pone.0130123. eCollection 2015. PubMed PMID: 26068928; PubMed Central PMCID: PMC4465973.
  • Emperador DM, Velasquez DE, Estivariz CF, Lopman B, Jiang B, Parashar U, Anand A, Zaman K. Interference of Monovalent, Bivalent, and Trivalent OralPoliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh. Clin Infect Dis. 2015 Sep 8. pii: civ807. [Epub ahead of print] PubMed PMID: 26349548.
  • Estívariz CF, Anand A, Gary HE Jr, Rahman M, Islam J, Bari TI, Wassilak SG, Chu SY, Weldon WC, Pallansch MA, Heffelfinger JD, Luby SP, Zaman K.Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial. Lancet Infect Dis. 2015 Aug;15(8):898-904. doi: 10.1016/S1473-3099(15)00094-8. Epub 2015 Jun 17. PubMed PMID: 26093980.
  • Etsano A, Gunnala R, Shuaib F, Damisa E, Mkanda P, Ticha JM, Banda R, Korir C, Chevez AE, Enemaku O, Corkum M, Davis LB, Nganda GW, Burns CC, Wassilak SG, Vertefeuille JF. Progress Toward Poliomyelitis Eradication - Nigeria, January 2014-July 2015. MMWR Morb Mortal Wkly Rep. 2015 Aug 21;64(32):878-82. PubMed PMID: 26292207.
  • Farag NH, Wadood MZ, Safdar RM, Ahmed N, Hamdi S, Tangermann RH, Ehrhardt D. Progress Toward Poliomyelitis Eradication - Pakistan, January 2014-September 2015. MMWR Morb Mortal Wkly Rep. 2015 Nov 20;64(45):1271-5. doi: 10.15585/mmwr.mm6445a4. PubMed PMID: 26584026.
  • Gamage D, Palihawadana P, Mach O, Weldon WC, Oberste SM, Sutter RW. Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014. J Epidemiol Glob Health. 2015 Jul 9. pii: S2210-6006(15)00066-0. doi: 10.1016/j.jegh.2015.06.004. [Epub ahead of print] PubMed PMID: 26166424.
  • Hagan JE, Wassilak SG, Craig AS, Tangermann RH, Diop OM, Burns CC, Quddus A; Centers for Disease Control and Prevention (CDC). Progress toward polio eradication - worldwide, 2014-2015. MMWR Morb Mortal Wkly Rep. 2015 May 22;64(19):527-31. PubMed PMID: 25996095.
  • Hampton, LM. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016. Immunization Systems Management Group of the Global Polio Eradication Initiative. MMWR Morb Mortal Wkly Rep. 2015 Jul 3;64 (25):699-702.
  • Kalkowska DA, Duintjer Tebbens RJ, Grotto I, Shulman LM, Anis E, Wassilak SG, Pallansch MA, Thompson KM. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013. J Infect Dis. 2015 Jun 1;211(11):1800-12. doi: 10.1093/infdis/jiu674. Epub 2014 Dec 10. PubMed PMID: 25505296.
  • Kalkowska DA, Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SG, Thompson KM. Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination. BMC  Infect Dis. 2015 Feb 18;15:66. doi: 10.1186/s12879-015-0791-5. PubMed PMID: 25886823; PubMed Central PMCID: PMC4344758.
  • Mbaeyi C, Saatcioglu A, Tangermann RH, Hadler S, Ehrhardt D. Progress Toward Poliomyelitis Eradication - Afghanistan, January 2014‒August 2015. MMWR Morb Mortal Wkly Rep. 2015 Oct 23;64(41):1166-70. doi: 10.15585/mmwr.mm6441a2. PubMed PMID: 26492280.
  • Mir F, Quadri F, Mach O, Ahmed I, Bhatti Z, Khan A, Rehman NU, Durry E, Salama M, Oberste SM, Weldon WC, Sutter RW, Zaidi AK. Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial. Lancet Infect Dis. 2015 Aug;15(8):889-97. doi:10.1016/S1473-3099(15)00093-6. Epub 2015 Jun 17. PubMed PMID: 26093979.
  • Porter KA, Diop OM, Burns CC, Tangermann RH, Wassilak SG. Tracking progress toward polio eradication - worldwide, 2013-2014. MMWR Morb Mortal Wkly Rep. 2015 Apr 24;64(15):415-20. PubMed PMID: 25905895.
  • Previsani N, Tangermann RH, Tallis G, Jafari HS. World Health Organization Guidelines for Containment of Poliovirus Following Type-Specific Polio Eradication - Worldwide, 2015. MMWR Morb Mortal Wkly Rep. 2015 Aug 28;64(33):913-7. PubMed PMID: 26313474.
  • Resik S, Tejeda A, Fonseca M, Sein C, Hung LH, Martinez Y, Diaz M, Okayasu H, Sutter RW. Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies. Trials Vaccinol. 2015. http://dx.doi.org/10.1016-j.trivac.2015.08.001.
  • Resik S, Tejeda A, Mach O, Fonseca M, Diaz M, Alemany N, Garcia G, Hung LH, Martinez Y, Sutter R. Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba. Vaccine. 2015 Jan 3;33(2):307-13. doi: 10.1016/j.vaccine.2014.11.025. Epub 2014 Nov 22. PubMed PMID: 25448109.
  • Resik S, Tejeda A, Mach O, Sein C, Molodecky N, Jarrahian C, Saganic L, Zehrung D, Fonseca M, Diaz M, Alemany N, Garcia G, Hung LH, Martinez Y, Sutter RW. Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicity. Vaccine. 2015 Oct 26;33(43):5873-7. doi: 10.1016/j.vaccine.2015.06.071. Epub 2015 Jul 17. PubMed PMID: 26192350.
  • Resik S, Tejeda A, Mach O, Sein C, Molodecky N, Jarrahian C, Saganic L, Zehrung D, Fonseca M, Diaz M, Alemany N, Garcia G, Hung LH, Martinez Y, Sutter RW. Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicity. Vaccine. 2015 Oct 26;33(43):5873-7. doi: 10.1016/j.vaccine.2015.06.071. Epub 2015 Jul 17. PubMed PMID: 26192350.
  • Saleem AF, Mach O, Quadri F, Khan A, Bhatti Z, Rehman NU, Zaidi S, Weldon WC, Oberste SM, Salama M, Sutter RW, Zaidi AK. Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan. Vaccine. 2015 Jun 4;33(24):2757-63. doi: 10.1016/j.vaccine.2015.04.055. Epub 2015 Apr 24. PubMed PMID: 25917673; PubMed Central PMCID: PMC4447616.
  • Sutter RW, Bahl S, Deshpande JM, Verma H, Ahmad M, Venugopal P, Rao JV, Agarkhedkar S, Lalwani SK, Kunwar A, Sethi R, Takane M, Mohanty L, Chatterjee A, John TJ, Jafari H, Aylward RB. Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomized controlled trial. Lancet. 2015 Sep 17. pii: S0140-6736(15)00237-8. doi: 10.1016/S0140-6736(15)00237-8. [Epub ahead of print] PubMed PMID: 26388534.
  • Walker AT, Williams AJ, Gary HE Jr, Pallansch MA, Wassilak SG, Oberste MS. Effect of time at temperature on wild poliovirus titers in stool specimens. Virology. 2015 Aug;482:28-31. doi: 10.1016/j.virol.2015.03.005. Epub 2015 Mar 30. PubMed PMID: 25817402; PubMed Central PMCID: PMC4620922.
  • Zuo S, Rodewald L, Sutter R, Fournier-Caruana, J, Schluter W, Diorditsa S.  World Health Organization Experts’ Clarification of Key Technical Issues on Implementation of the Polio Endgame Strategic Plan in China. Chinese Journal of Vaccines and Immunization 2015;12(4).

2014

  • Abdelwahab J, Dietz V, Eggers R, Maher C, Olaniran M, Sandhu H, Vandelaer J. Strengthening the partnership between routine immunization and the global polio eradication initiative to achieve eradication and assure sustainability. J Infect Dis. 2014 Nov 1;210 Suppl 1:S498-503. doi: 10.1093/infdis/jiu041. Review. PubMed PMID: 25316872.
  • Ado JM, Etsano A, Shuaib F, Damisa E, Mkanda P, Gasasira A, Banda R, Korir C, Johnson T, Dieng B, Corkum M, Enemaku O, Mataruse N, Ohuabunwo C, Baig S, Galway M, Seaman V, Wiesen E, Vertefeuille J, Ogbuanu IU, Armstrong G, Mahoney FJ. Progress toward poliomyelitis eradication in Nigeria. J Infect Dis. 2014 Nov 1;210 Suppl 1:S40-9. doi: 10.1093/infdis/jiu318. PubMed PMID: 25316862.
  • Alexander JP Jr, Zubair M, Khan M, Abid N, Durry E. Progress and peril: poliomyelitis eradication efforts in Pakistan, 1994-2013. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S152-61. doi: 10.1093/infdis/jiu450. PubMed PMID: 25316830.
  • Alleman MM, Wannemuehler KA, Weldon WC, Kabuayi JP, Ekofo F, Edidi S, Mulumba A, Mbule A, Ntumbannji RN, Coulibaly T, Abiola N, Mpingulu M, Sidibe K, Oberste MS. Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged ≥15 years in the Democratic Republic of the Congo, 2010-2011, informed by a pre-outbreak poliovirus immunity assessment. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S62-73. doi: 10.1093/infdis/jiu282. PubMed PMID: 25316879.
  • Anand A, Pallansch MA, Estivariz CF, Gary H, Wassilak SG. Estimating the likely coverage of inactivated poliovirus vaccine in routine immunization: evidence from demographic and health surveys. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S465-74. doi: 10.1093/infdis/jiu343. PubMed PMID: 25316869.
  • Andre M, Wolff CG, Tangermann RH, Chenoweth P, Tallis G,  , Wassilak SG; Centers for Disease Control and Prevention (CDC). Assessing and mitigating the risks for polio outbreaks in polio-free countries - Africa, 2013-2014. MMWR Morb Mortal Wkly Rep. 2014 Aug 29; 63(34):756-61. PubMed PMID: 25166927.
  • Asghar H, Diop OM, Weldegebriel G, Malik F, Shetty S, El Bassioni L, Akande AO, Al Maamoun E, Zaidi S, Adeniji AJ, Burns CC, Deshpande J, Oberste MS, Lowther SA. Environmental surveillance for polioviruses in the Global Polio Eradication Initiative. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S294-303. doi: 10.1093/infdis/jiu384. Review. PubMed PMID: 25316848.
  • Bahl S, Estívariz CF, Sutter RW, Sarkar BK, Verma H, Jain V, Agrawal A, Rathee M, Shukla H, Pathyarch SK, Sethi R, Wannemuehler KA, Jafari H, Deshpande JM. Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern India. J Infect Dis. 2014 Nov 1;210 Suppl 1:S243-51.  doi: 10.1093/infdis/jit492. PubMed PMID: 25316842.
  • Bahl S, Gary HE Jr, Jafari H, Sarkar BK, Pathyarch SK, Sethi R, Deshpande J. An acute flaccid paralysis surveillance-based serosurvey of poliovirus antibodies in Western Uttar Pradesh, India. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S234-42. doi: 10.1093/infdis/jiu379. PubMed PMID: 25316841.
  • Bahl S, Kumar R, Menabde N, Thapa A, McFarland J, Swezy V, Tangermann RH, Jafari HS, Elsner L, Wassilak SG, Kew OM, Cochi SL. Polio-free certification and lessons learned--South-East Asia region, March 2014. MMWR Morb Mortal Wkly Rep. 2014 Oct 24; 63(42):941-6. PubMed PMID: 25340910.
  • Blake IM, Martin R, Goel A, Khetsuriani N, Everts J, Wolff C, Wassilak S, Aylward RB, Grassly NC. The role of older children and adults in wild poliovirus transmission. Proc Natl Acad Sci U S A. 2014 Jul 2; 111(29):10604-9. doi: 10.1073/pnas.1323688111. Epub 2014 Jul 7. PubMed PMID: 25002465; PubMed Central PMCID: PMC4115498.
  • Brown AE, Okayasu H, Nzioki MM, Wadood MZ, Chabot-Couture G, Quddus A, Walker G, Sutter RW. Lot quality assurance sampling to monitor supplemental immunization activity quality: an essential tool for improving performance in polio endemic countries. J Infect Dis. 2014 Nov 1;210 Suppl 1:S333-40. doi: 10.1093/infdis/jit816. Review. PubMed PMID: 25316852.
  • Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014 Nov 1;210 Suppl 1:S283-93. doi: 10.1093/infdis/jiu295. Review. PubMed PMID: 25316847.
  • Cardemil CV, Jonas A, Gerber S, Weldon WC 3rd, Oberste MS, Beukes A, Sawadogo S, Patel SV, Zeko S, Muroua C, Gaeb E, Wannemuehler K, Goodson JL. Poliovirus immunity among pregnant females aged 15-44 years, Namibia, 2010. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S136-42. doi: 10.1093/infdis/jiu086. PubMed PMID: 25316828.
  • Cardemil CV, Rathee M, Gary H, Wannemuehler K, Anand A, Mach O, Bahl S, Wassilak S,
  • Cardemil CV, Rathee M, Gary H, Wannemuehler K, Anand A, Mach O, Bahl S, Wassilak S, Chu SY,   Khera A, Jafari HS, Pallansch MA. Surveillance during an era of rapidly changing poliovirus epidemiology in India: the role of one vs. two stool specimens in poliovirus detection, 2000-2010. Epidemiol Infect. 2014 Jan;142(1):163-71. doi: 10.1017/S0950268813000800. Epub 2013 Apr 18. PubMed PMID: 23594458.
  • Chandir S, Ahamed KU, Baqui AH, Sutter RW, Okayasu H, Pallansch MA, Oberste MS, Moulton LH, Halsey NA. Effect of buffer on the immune response to trivalent oral poliovirus vaccine in Bangladesh: a community based randomized controlled trial. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S390-7. doi: 10.1093/infdis/jiu378. PubMed PMID: 25316860.
  • Chu SY, Khera A, Jafari HS, Pallansch, MA. Surveillance during an era of rapidly changing poliovirus epidemiology in India: the role of one vs. two stool specimens in poliovirus detection, 2000-2010. Epidemiology and Infection 2014; 142:163–71.
  • Cochi SL, Freeman A, Guirguis S, Jafari H, Aylward B. Global polio eradication initiative: lessons learned and legacy. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S540-6. doi: 10.1093/infdis/jiu345. Review. PubMed PMID: 25316878.
  • Cochi SL, Jafari HS, Armstrong GL, Sutter RW, Linkins RW, Pallansch MA, Kew O, Aylward RB. A world without polio. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S1-4.  doi: 10.1093/infdis/jiu383. PubMed PMID: 25316822.
  • Deshpande JM, Bahl S, Sarkar BK, Estívariz CF, Sharma S, Wolff C, Sethi R, Pathyarch SK, Jain V, Gary HE Jr, Pallansch MA, Jafari H. Assessing population immunity in a persistently high-risk area for wild poliovirus transmission in India: a serological study in Moradabad, Western Uttar Pradesh. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S225-33. doi: 10.1093/infdis/jiu204. PubMed PMID: 25316839.
  • Diop OM, Burns CC, Wassilak SG, Kew OM; Centers for Disease Control andPrevention (CDC). Update on vaccine-derived polioviruses - worldwide, July2012-December 2013. MMWR Morb Mortal Wkly Rep. 2014 Mar 21; 63(11):242-8. PubMed PMID: 24647401.
  • Duintjer Tebbens RJ, Kalkowska DA, Wassilak SG, Pallansch MA, Cochi SL, Thompson KM. The potential impact of expanding target age groups for polio immunization campaigns. BMC Infect Dis. 2014 Jan 29; 14:45. doi: 10.1186/1471-2334-14-45. PubMed PMID: 24472313; PubMed Central PMCID: PMC3918103.
  • Esteves-Jaramillo A, Estívariz CF, Peñaranda S, Richardson VL, Reyna J, Coronel DL, Carrión V, Landaverde JM, Wassilak SG, Pérez-Sánchez EE, López-Martínez I, Burns CC, Pallansch MA. Detection of vaccine-derived polioviruses in Mexico using environmental surveillance. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S315-23. doi: 10.1093/infdis/jiu183. PubMed PMID: 25316850.
  • Etsano A, Gunnala R, Shuaib F, Damisa E, Mkanda P, Banda R, Korir C, Enemaku O, Corkum M, Usman S, Davis LB, Nganda Gw, Burns CC, Mahoney F, Vertefeuille JF; Centers for Disease Control and Prevention (CDC). Progress toward poliomyelitis eradication--Nigeria, January 2013-September 2014. MMWR Morb Mortal Wkly Rep. 2014 Nov 21; 63(46):1059-63. PubMed PMID: 25412063.
  • Farag NH, Alexander J, Hadler S, Quddus A, Durry E, Wadood MZ, Tangermann RH, Ehrhardt D; Centers for Disease Control and Prevention (CDC). Progress toward poliomyelitis eradication--Afghanistan and Pakistan, January 2013-August 2014. MMWR Morb Mortal Wkly Rep. 2014 Oct 31; 63(43):973-7. PubMed PMID: 25356605.
  • Gammino VM, Nuhu A, Chenoweth P, Manneh F, Young RR, Sugerman DE, Gerber S, Abanida E, Gasasira A. Using geographic information systems to track polio vaccination team performance: pilot project report. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S98-101. doi: 10.1093/infdis/jit285. PubMed PMID: 25316882.
  • Gammino VM, Nuhu A, Gerber S, Gasasira A, Sugerman DE, Manneh F, Chenoweth P, Kurnit MR, Abanida EA. An evaluation of polio supplemental immunization activities in Kano, Katsina, and Zamfara States, Nigeria: lessons in progress. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S91-7. doi: 10.1093/infdis/jiu228. PubMed PMID: 25316881.
  • Haque R, Snider C, Liu Y, Ma JZ, Liu L, Nayak U, Mychaleckyj JC, Korpe P, Mondal D, Kabir M, Alam M, Pallansch M, Oberste MS, Weldon W, Kirkpatrick BD, Petri WA Jr. Oral polio vaccine response in breast fed infants with malnutrition and diarrhea. Vaccine. 2014 Jan 16; 32(4):478-82. doi: 10.1016/j.vaccine.2013.11.056. Epub 2013 Dec 2. PubMed PMID: 24300591.
  • Iliyasu Z, Nwaze E, Verma H, Mustapha AO, Weldegebriel G, Gasasira A, Wannemuehler KA, Pallansch MA, Gajida AU, Pate M, Sutter RW. Survey of poliovirus antibodies in Kano, Northern Nigeria. Vaccine. 2014 Mar 10; 32(12):1414-20. doi: 10.1016/j.vaccine.2013.08.060. Epub 2013 Sep 14. PubMed PMID: 24041545.
  • Jafari H, Deshpande JM, Sutter RW, Bahl S, Verma H, Ahmad M, Kunwar A, Vishwakarma R, Agarwal A, Jain S, Estivariz C, Sethi R, Molodecky NA, Grassly NC, Pallansch MA, Chatterjee A, Aylward RB. Polio eradication. Efficacy of inactivated poliovirus vaccine in India. Science. 2014 Aug 22;345(6199):922-5. doi: 10.1126/science.1255006. PubMed PMID: 25146288.
  • Kalkowska DA, Duintjer Tebbens RJ, Grotto I, Shulman LM, Anis E, Wassilak SG, Pallansch MA, Thompson KM. Modeling Options to Manage Type 1 Wild Poliovirus Imported into Israel in 2013. J Infect Dis. 2014 Dec 10. pii: jiu674. [Epub ahead of print] PubMed PMID: 25505296.
  • Kamadjeu R, Mahamud A, Webeck J, Baranyikwa MT, Chatterjee A, Bile YN, Birungi J, Mbaeyi C, Mulugeta A. Polio outbreak investigation and response in Somalia, 2013. J Infect Dis. 2014 Nov 1;210 Suppl 1:S181-6. doi: 10.1093/infdis/jiu453. PubMed PMID: 25316834.
  • Kew OM, Cochi SL, Jafari HS, Wassilak SG, Mast EE, Diop OM, Tangermann RH, Armstrong GL; Centers for Disease Control and Prevention (CDC). Possible eradication of wild poliovirus type 3--worldwide, 2012. MMWR Morb Mortal Wkly Rep. 2014 Nov 14; 63(45):1031-3. PubMed PMID: 25393222.
  • Khetsuriani N, Pfeifer D, Deshevoi S, Gavrilin E, Shefer A, Butler R, Jankovic D, Spataru R, Emiroglu N, Martin R. Challenges of maintaining polio-freestatus of the European Region. J Infect Dis. 2014 Nov 1;210 Suppl 1:S194-207. doi: 10.1093/infdis/jiu096. PubMed PMID: 25316836.
  • Kisjes KH, Duintjer Tebbens RJ, Wallace GS, Pallansch MA, Cochi SL, Wassilak SG, Thompson KM. Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccination. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S424-33. doi:10.1093/infdis/jit843. PubMed PMID: 25316864.
  • Kretsinger K, Gasasira A, Poy A, Porter KA, Everts J, Salla M, Brown KH, Wassilak SG, Nshimirimana D. Polio eradication in the World Health Organization African Region, 2008-2012. J Infect Dis. 2014 Nov 1;210 Suppl 1:S23-39. doi: 10.1093/infdis/jiu408. Review. PubMed PMID: 25316840.
  • Levitt A, Diop OM, Tangermann RH, Paladin F, Kamgang JB, Burns CC, Chenoweth PJ, Goel A, Wassilak SG; Centers for Disease Control and Prevention (CDC). Surveillance systems to track progress toward global polio eradication - worldwide, 2012-2013. MMWR Morb Mortal Wkly Rep. 2014 Apr 25; 63(16):356-61.PubMed PMID: 24759658.
  • Li L, Ivanova O, Driss N, Tiongco-Recto M, da Silva R, Shahmahmoodi S, Sazzad HM, Mach O, Kahn AL, Sutter RW. Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S368-72. doi: 10.1093/infdis/jiu065. PubMed PMID: 25316857.
  • Mach O, Tangermann RH, Wassilak SG, Singh S, Sutter RW. Outbreaks of paralytic poliomyelitis during 1996-2012: the changing epidemiology of a disease in the final stages of eradication. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S275-82. doi: 10.1093/infdis/jit454. PubMed PMID: 25316846.
  • Mach O, Verma H, Khandait DW, Sutter RW, O'Connor PM, Pallansch MA, Cochi SL, Linkins RW, Chu SY, Wolff C, Jafari HS. Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: analysis of contact and enhanced community surveillance, 2009. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S252-8. doi: 10.1093/infdis/jit234. PubMed PMID: 25316843.
  • Mahamud A, Kamadjeu R, Webeck J, Mbaeyi C, Baranyikwa MT, Birungi J, Nurbile  Y, Ehrhardt D, Shukla H, Chatterjee A, Mulugeta A. Effectiveness of oral polio vaccination against paralytic poliomyelitis: a matched case-control study in Somalia. J Infect Dis. 2014 Nov 1;210 Suppl 1:S187-93. doi: 10.1093/infdis/jiu261. PubMed PMID: 25316835.
  • Mbaeyi C, Kamadjeu R, Mahamud A, Webeck J, Ehrhardt D, Mulugeta A. Progress toward polio eradication--Somalia, 1998-2013. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S173-80. doi: 10.1093/infdis/jit808. PubMed PMID: 25316833.
  • Michael CA, Ashenafi S, Ogbuanu IU, Ohuabunwo C, Sule A, Corkum M, Mackay S, Storms AD, Achari P, Biya O, Nguku P, Newberry D, Bwaka A, Mahoney F; OPV Campaign Missed Children Study Team. An evaluation of community perspectives and contributing factors to missed children during an oral polio vaccination campaign--Katsina State, Nigeria. J Infect Dis. 2014 Nov 1;210 Suppl 1:S131-5. doi: 10.1093/infdis/jiu288. PubMed PMID: 25316827.
  • Michael CA, Ogbuanu IU, Storms AD, Ohuabunwo CJ, Corkum M, Ashenafi S, Achari P, Biya O, Nguku P, Mahoney F; NSTOP OPV Refusal Study Team. An assessment of the reasons for oral poliovirus vaccine refusals in northern Nigeria. J Infect Dis. 2014 Nov 1;210 Suppl 1:S125-30. doi: 10.1093/infdis/jiu436. PubMed PMID: 25316826.
  • Moturi EK, Porter KA, Wassilak SG, Tangermann RH, Diop OM, Burns CC, Jafari H; EIS officer, CDC. Progress toward polio eradication--Worldwide, 2013-2014. MMWR Morb Mortal Wkly Rep. 2014 May 30; 63(21):468-72. PubMed PMID: 24871252.
  • Moulsdale HJ, Khetsuriani N, Deshevoi S, Butler R, Simpson J, Salisbury D. Simulation exercises to strengthen polio outbreak preparedness: experience of the World Health Organization European Region. J Infect Dis. 2014 Nov 1;210 Suppl 1:S208-15. doi: 10.1093/infdis/jiu120. PubMed PMID: 25316837.
  • Ndiaye SM, Ahmed MA, Denson M, Craig AS, Kretsinger K, Cherif B, Kandolo P, Moto DD, Richelot A, Tuma J. Polio outbreak among nomads in Chad: outbreak response and lessons learned. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S74-84. doi: 10.1093/infdis/jit564. Epub 2013 Oct 23. PubMed PMID: 24154734.
  • O'Connor PM, Allison R, Thapa A, Bahl S, Chunsuittiwat S, Hasan M, Khan Z, Sedai T. Update on polio eradication in the World Health Organization South-East Asia Region, 2013. J Infect Dis. 2014 Nov 1;210 Suppl 1:S216-24. doi: 10.1093/infdis/jit585. Review. PubMed PMID: 25316838.
  • Okayasu H, Sutter RW, Jafari HS, Takane M, Aylward RB. Affordable inactivated poliovirus vaccine: strategies and progress. J Infect Dis. 2014 Nov 1;210 Suppl 1:S459-64. doi: 10.1093/infdis/jiu128. Review. PubMed PMID: 25316868.
  • Platt LR, Estívariz CF, Sutter RW. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S380-9. doi: 10.1093/infdis/jiu184. Review. PubMed PMID: 25316859.
  • Resik S, Tejeda A, Fonseca M, Alemañi N, Diaz M, Martinez Y, Garcia G, Okayasu H, Burton A, Bakker WA, Verdijk P, Sutter RW. Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: a phase I Trial in healthy adults in Cuba. Vaccine. 2014 Sep 22; 32(42):5399-404. doi: 10.1016/j.vaccine.2014.07.109. Epub 2014 Aug 12. PubMed PMID: 25131734.
  • Resik S, Tejeda A, Mach O, Fonseca M, Diaz M, Alemany N, Garcia G, Hung LH, Martinez Y, Sutter R. Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: A randomized controlled trial in Cuba. Vaccine. 2015 Jan 3; 33(2):307-13. doi: 10.1016/j.vaccine.2014.11.025. Epub 2014 Nov 22. PubMed PMID: 25448109.
  • Sazzad HM, Rainey JJ, Kahn AL, Mach O, Liyanage JB, Alam AN, Kawser CA, Hossain A, Sutter R, Luby SP. Screening for long-term poliovirus excretion among children with primary immunodeficiency disorders: preparation for the polio posteradication era in Bangladesh. J Infect Dis. 2014 Nov 1;210 Suppl 1:S373-9. doi: 10.1093/infdis/jiu221. PubMed PMID: 25316858.
  • Sheikh MA, Makokha F, Hussein AM, Mohamed G, Mach O, Humayun K, Okiror S, Abrar L, Nasibov O, Burton J, Unshur A, Wannemuehler K, Estivariz CF; Centers for Disease Control and Prevention (CDC). Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013. MMWR Morb Mortal Wkly Rep. 2014 Mar 21; 63(11):237-41. PubMed PMID: 24647400.
  • Simpson DM, Sadr-Azodi N, Mashal T, Sabawoon W, Pardis A, Quddus A, Garrigos C, Guirguis S, Zahoor Zaidi SS, Shaukat S, Sharif S, Asghar H, Hadler SC. Polio eradication initiative in Afghanistan, 1997-2013. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S162-72. doi: 10.1093/infdis/jiu022. PubMed PMID: 25316832.
  • Sutter RW, Platt L, Mach O, Jafari H, Aylward RB. The new polio eradication end game: rationale and supporting evidence. J Infect Dis. 2014 Nov 1;210 Suppl 1:S434-8. doi: 10.1093/infdis/jiu222. Review. PubMed PMID: 25316865.
  • Verdijk P, Rots NY, van Oijen MG, Weldon WC, Oberste MS, Okayasu H, Sutter RW, Bakker WA. Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants. Vaccine. 2014 Sep 3;32(39):4938-44. doi: 10.1016/j.vaccine.2014.07.029. Epub 2014 Jul 18. PubMed PMID: 25043278.
  • Wahjuhono G, Revolusiana, Widhiastuti D, Sundoro J, Mardani T, Ratih WU, Sutomo R, Safitri I, Sampurno OD, Rana B, Roivainen M, Kahn AL, Mach O, Pallansch MA, Sutter RW. Switch from oral to inactivated poliovirus vaccine in Yogyakarta Province, Indonesia: summary of coverage, immunity, and environmental surveillance. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S347-52. doi: 10.1093/infdis/jiu060. PubMed PMID: 25316854.
  • Walker AT, Sodha S, Warren WC, Sergon K, Kiptoon S, Ogange J, Ahmeda AH, Eshetu M, Corkum M, Pillai S, Scobie H, Mdodo R, Tack DM, Halldin C, Appelgren K, Kretsinger K, Bensyl DM, Njeru I, Kolongei T, Muigai J, Ismail A, Okiror SO. Forewarning of poliovirus outbreaks in the Horn of Africa: an assessment of acute flaccid paralysis surveillance and routine immunization systems in Kenya. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S85-90. doi: 10.1093/infdis/jiu149. PubMed PMID: 25316880.
  • Wassilak SG, Oberste MS, Tangermann RH, Diop OM, Jafari HS, Armstrong GL. Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S5-15. doi: 10.1093/infdis/jiu456. Review. PubMed PMID: 25316873.
  • Waziri NE, Ohuabunwo CJ, Nguku PM, Ogbuanu IU, Gidado S, Biya O, Wiesen ES, Vertefeuille J, Townes D, Oyemakinde A, Nwanyanwu O, Gassasira A, Mkanda P, Muhammad AJ, Elmousaad HA, Nasidi A, Mahoney FJ. Polio eradication in Nigeria and the role of the National Stop Transmission of Polio program, 2012-2013. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S111-7. doi: 10.1093/infdis/jiu199. Review. PubMed PMID: 25316824.
  • Wright PF, Wieland-Alter W, Ilyushina NA, Hoen AG, Arita M, Boesch AW, Ackerman ME, van der Avoort H, Oberste MS, Pallansch MA, Burton AH, Jaffar MA, Sutter RW. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination. J Infect Dis. 2014 May 15; 209(10):1628-34. doi: 10.1093/infdis/jit671. Epub 2014 Jan 23. PubMed PMID: 24459191.
  • Yusuf N, de Wee R, Foster N, Watkins MA, Tiruneh D, Chauvin C, Bossarte R, Mandlhate C, Jack A, Gumede N, Mawela A, Burns CC, Pallansch MA, Allies T, Rainey J, Mataruse N, Nshimirimana D. Outbreak of type 1 wild poliovirus infection in adults, Namibia, 2006. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S353-60. doi: 10.1093/infdis/jiu069. PubMed PMID: 25316855.

Rotavirus

2015

  • Ngabo F, Levin A, Wang SA, Gatera M, Rugambwa C, Kayonga C, Donnen P, Lepage  P, Hutubessy R. A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda. Vaccine. 2015 Oct 29. pii: S0264-410X(15)01437-1. doi: 10.1016/j.vaccine.2015.10.022. [Epub ahead of print]  PubMed PMID: 26519548.
  • Parashar UD, Cortese MM, Payne DC, Lopman B, Yen C, Tate JE. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines. Vaccine. 2015 Jun 27. pii: S0264-410X(15)00778-1. doi: 10.1016/j.vaccine.2015.05.094. [Epub ahead of print] Review. PubMed PMID: 26122581.
  • Parashar UD, Cortese MM, Payne DC, Lopman B, Yen C, Tate JE. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines. Vaccine. 2015 Nov 27;33 Suppl 4:D55-D59. doi: 10.1016/j.vaccine.2015.05.094. Epub 2015 Jun 27. Review. PubMed PMID: 26122581.
  • Premkumar PS, Parashar UD, Gastanaduy PA, McCracken JP, de Oliveira LH, Payne DC, Patel MM, Tate JE, Lopman BA. Reduced rotavirus vaccine effectiveness among children born during the rotavirus season: a pooled analysis of 5 case-control studies from the Americas. Clin Infect Dis. 2015 Apr 1;60(7):1075-8. doi: 10.1093/cid/ciu956. Epub 2014 Dec 1. PubMed PMID: 25452592.
  • Suarez-Castaneda E, Burnett E, Elas M, Baltrons R, Pezzoli L, Flannery B, Kleinbaum D, Oliveira LH, Danovaro-Holliday MC. Catching-up with pentavalent vaccine: Exploring reasons behind lower rotavirus vaccine coverage in El Salvador. Vaccine. 2015 Aug 8. pii: S0264-410X(15)01096-8. doi: 10.1016/j.vaccine.2015.07.092. [Epub ahead of print] PubMed PMID: 26263200.
  • Waku-Kouomou D, Esona MD, Pukuta E, Gouandijka-Vasilache I, Boula A, Dahl BA, Mondonge V, Mekontso D, Guifara G, Mbary-Daba R, Lewis J, Yahaya AA, Mwenda JM, Cavallaro KF, Gody JC, Muyembe JJ, Ndombo PK, Bowen MD. Strengthening laboratory capacity through the surveillance of rotavirus gastroenteritis in Central Africa: the Surveillance Épidémiologique en Afrique Centrale (SURVAC) Project. Trop Med Int Health. 2015 Nov 2. doi: 10.1111/tmi.12631. [Epub ahead of print] PubMed PMID: 26523367.

2014

  • Agócs MM, Serhan F, Yen C, Mwenda JM, de Oliveira LH, Teleb N, Wasley A, Wijesinghe PR, Fox K, Tate JE, Gentsch JR, Parashar UD, Kang G; Department of Immunization, Vaccines, and Biologicals, World Health Organization (WHO), Geneva, Switzerland; Centers for Disease Control and Prevention (CDC). WHO global rotavirus surveillance network: a strategic review of the first 5 years, 2008-2012. MMWR Morb Mortal Wkly Rep. 2014 Jul 25; 63(29):634-7. Review. PubMed PMID: 25055187.
  • Banga-Mingo V, Waku-Kouomou D, Gody JC, Esona MD, Yetimbi JF, Mbary-Daba R, Dahl BA, Dimanche L, Koyazegbe Td, Tricou V, Cavallaro KF, Guifara G, Bowen MD, Gouandjika-Vasilache I. Molecular surveillance of rotavirus infection in Bangui, Central African Republic, October 2011-September 2013. Infect Genet Evol. 2014 Dec; 28:476-9. doi: 10.1016/j.meegid.2014.08.023. Epub 2014 Sep 2. PubMed PMID: 25193563.
  • Boula A, Waku-Kouomou D, Njiki Kinkela M, Esona MD, Kemajou G, Mekontso D, Seheri M, Ngum Ndze V, Emah I, Ela S, Dahl BA, Kobela M, Cavallaro KF, Etoundi Mballa GA, Genstch JR, Bowen MD, Koki Ndombo P. Molecular surveillance of rotavirus strains circulating in Yaoundé, Cameroon, September 2007-December 2012. Infect Genet Evol. 2014 Dec; 28:470-5. doi: 10.1016/j.meegid.2014.08.019. Epub 2014 Sep 16. PubMed PMID: 25220619.
  • Chhabra P, Samoilovich E, Yermalovich M, Chernyshova L, Gheorghita S, Cojocaru R, Shugayev N, Sahakyan G, Lashkarashvili M, Chubinidze M, Zakhashvili K, Videbaek D, Wasley A, Vinjé J. Viral gastroenteritis in rotavirus negative hospitalized children <5 years of age from the independent states of the former Soviet Union. Infect Genet Evol. 2014 Dec; 28:283-8. doi: 10.1016/j.meegid.2014.10.013. Epub 2014 Oct 19. PubMed PMID: 25460823.
  • Glass RI, Parashar U, Patel M, Gentsch J, Jiang B. Rotavirus vaccines: successes and challenges. J Infect. 2014 Jan; 68 Suppl 1:S9-18. doi: 10.1016/j.jinf.2013.09.010. Epub 2013 Oct 22. Review. PubMed PMID: 24156947.
  • Mwenda JM, Tate JE, Parashar UD, Mihigo R, Agócs M, Serhan F, Nshimirimana D. African rotavirus surveillance network: a brief overview. Pediatr Infect Dis J. 2014 Jan; 33 Suppl 1:S6-8. doi: 10.1097/INF.0000000000000174. Review. PubMed PMID: 24343616.
  • Pukuta ES, Esona MD, Nkongolo A, Seheri M, Makasi M, Nyembwe M, Mondonge V, Dahl BA, Mphahlele MJ, Cavallaro K, Gentsch J, Bowen MD, Waku-Kouomou D, Muyembe JJ; SURVAC Working Group. Molecular surveillance of rotavirus infection in the Democratic Republic of the Congo August 2009 to June 2012. Pediatr Infect Dis J. 2014 Apr; 33(4):355-9. doi: 10.1097/INF.0000000000000212. PubMed PMID: 24637513.
  • Semeiko GV, Yermalovich MA, Poliakova N, Mijatovic-Rustempasic S, Kerin TK, Wasley A, Videbaek D, Gentsch JR, Bowen MD, Samoilovich EO. Rotavirus genotypes in Belarus, 2008-2012. Infect Genet Evol. 2014 Dec; 28:480-5. doi: 10.1016/j.meegid.2014.09.007. Epub 2014 Sep 16. PubMed PMID: 25218086.
  • Yen C, Tate JE, Hyde TB, Cortese MM, Lopman BA, Jiang B, Glass RI, Parashar UD. Rotavirus vaccines: current status and future considerations. Hum Vaccin Immunother. 2014; 10(6):1436-48. doi: 10.4161/hv.28857. Epub 2014 Apr 22. PubMed PMID: 24755452.

Typhoid

2015

  • Carias C, Walters MS, Wefula E, Date KA, Swerdlow DL, Vijayaraghavan M, Mintz E. Economic evaluation of typhoid vaccination in a prolonged typhoid outbreak setting: the case of Kasese district in Uganda. Vaccine. 2015 Apr 21;33(17):2079-85. doi: 10.1016/j.vaccine.2015.02.027. Epub 2015 Feb 21. PubMed PMID: 25712333.
  • Date KA, Bentsi-Enchill A, Marks F, Fox K. Typhoid fever vaccination strategies. Vaccine. 2015 Jun 19;33 Suppl 3:C55-61. doi: 10.1016/j.vaccine.2015.04.028. Epub 2015 Apr 19. Review. PubMed PMID: 25902360.

2014

  • Blum LS, Dentz H, Chingoli F, Chilima B, Warne T, Lee C, Hyde T, Gindler J, Sejvar J, Mintz ED. Formative investigation of acceptability of typhoid vaccine during a typhoid fever outbreak in Neno District, Malawi. Am J Trop Med Hyg. 2014 Oct; 91(4):729-37. doi: 10.4269/ajtmh.14-0067. Epub 2014 Jul 7. PubMed PMID: 25002303; PubMed Central PMCID: PMC4183395.
  • Date KA, Bentsi-Enchill AD, Fox KK, Abeysinghe N, Mintz ED, Khan MI, Sahastrabuddhe S, Hyde TB; Centers for Disease Control and Prevention (CDC). Typhoid Fever surveillance and vaccine use - South-East Asia and Western Pacific regions, 2009-2013. MMWR Morb Mortal Wkly Rep. 2014 Oct 3; 63(39):855-60. PubMed PMID: 25275329.
  • Scobie HM, Nilles E, Kama M, Kool JL, Mintz E, Wannemuehler KA, Hyde TB, Dawainavesi A, Singh S, Korovou S, Jenkins K, Date K. Impact of a targeted typhoid vaccination campaign following cyclone Tomas, Republic of Fiji, 2010. Am J Trop Med Hyg. 2014 Jun; 90(6):1031-8. doi: 10.4269/ajtmh.13-0728. Epub 2014 Apr 7. PubMed PMID: 24710618; PubMed Central PMCID: PMC4047725.
  • Thompson CN, Kama M, Acharya S, Bera U, Clemens J, Crump JA, Dawainavesi A, Dougan G, Edmunds WJ, Fox K, Jenkins K, Khan MI, Koroivueta J, Levine MM, Martin LB, Nilles E, Pitzer VE, Singh S, Raiwalu RV, Baker S, Mulholland K. Typhoid fever in Fiji: a reversible plague? Trop Med Int Health. 2014 Oct; 19(10):1284-92. doi: 10.1111/tmi.12367. Epub 2014 Jul 25. PubMed PMID: 25066005.

Vaccine Programs

2015

  • Cardemil CV, Cullen KA, Harris L, Greby SM, Santibanez TA. Factors Associated With Provider Reporting of Child and Adolescent Vaccination History to Immunization Information Systems: Results From the National Immunization Survey, 2006-2012. J Public Health Manag Pract. 2015 Jun 9. [Epub ahead of print] PubMed PMID: 26062097.
  • Hsu CH, Farland J, Winters T, Gunn J, Caron D, Evans J, Osadebe L, Bethune L, McCollum AM, Patel N, Wilkins K, Davidson W, Petersen B, Barry MA; Centers for Disease Control and Prevention (CDC). Laboratory-acquired vaccinia virus infection in a recently immunized person--Massachusetts, 2013. MMWR Morb Mortal Wkly Rep. 2015 May 1;64(16):435-8. PubMed PMID: 25928468.
  • Jit M, Dang TT, Friberg I, Hoang VM, Pham Huy TK, Walker N, Nguyen VC, Tran ND, Toda K, Hutubessy R, Fox K, Nguyen TH. Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization. Vaccine. 2015 May 7;33 Suppl 1:A233-9. doi: 10.1016/j.vaccine.2014.12.017. PubMed PMID: 25919167.
  • Kaiser R, Chakauya JM, Shibeshi ME; Immunization, Vaccines, Emergencies Unit of the Inter-country Support Team for East, Southern Africa, World Health Organization Regional Office for Africa, Harare, Zimbabwe. Trends in differences between births and surviving infants reported for immunization program planning and external data sources in Eastern and Southern Africa 2000-2013. Vaccine. 2015 Jun 6. pii: S0264-410X(15)00747-1. doi: 10.1016/j.vaccine.2015.05.074. [Epub ahead of print] PubMed PMID: 26057134.
  • Kamadjeu R, Mulugeta A, Gupta D, Abshir Hirsi A, Belayneh A, Clark-Hattingh M, Adams C, Abed P, Kyeyune B, Ahmed T, Salih M, Biaou C, Toure B. Immunizing nomadic children and livestock - Experience in North East Zone of Somalia. Hum Vaccin Immunother. 2015 Sep 12:1-3. [Epub ahead of print] PubMed PMID: 26365693.
  • Kamadjeu R, Mulugeta A, Gupta D, Abshir Hirsi A, Belayneh A, Clark-Hattingh M, Adams C, Abed P, Kyeyune B, Ahmed T, Salih M, Biaou C, Toure B. Immunizing nomadic children and livestock - Experience in North East Zone of Somalia. Hum Vaccin Immunother. 2015 Nov 2;11(11):2637-9. doi: 10.1080/21645515.2015.1038682. Epub 2015 Sep 12. PubMed PMID: 26365693.
  • Kamadjeu R. Anti-vaxxing: a privilege of the fortunate. Lancet Infect Dis. 2015 Jul;15(7):766-7. doi: 10.1016/S1473-3099(15)00072-9. PubMed PMID: 26122447.
  • Odone A, Ferrari A, Spagnoli F, Visciarelli S, Shefer A, Pasquarella C, Signorelli C. Effectiveness of interventions that apply new media to improve vaccine uptake and vaccine coverage. Hum Vaccin Immunother. 2015;11(1):72-82. doi: 10.4161/hv.34313. Epub 2014 Nov 1. PubMed PMID: 25483518; PubMed Central PMCID: PMC4514191.
  • Sánchez D, Sodha SV, Kurtis HJ, Ghisays G, Wannemuehler KA, Danovaro-Holliday MC, Ropero-Álvarez AM. Vaccination Week in the Americas, 2011: an opportunity to assess the routine vaccination program in the Bolivarian Republic of Venezuela. BMC Public Health. 2015 Apr 17;15:395. doi: 10.1186/s12889-015-1723-4. PubMed PMID: 25909437; PubMed Central PMCID: PMC4409707.
  • Seither R, Calhoun K, Knighton CL, Mellerson J, Meador S, Tippins A, Greby SM, Dietz V. Vaccination Coverage Among Children in Kindergarten - United States, 2014-15 School Year. MMWR Morb Mortal Wkly Rep. 2015 Aug 28;64(33):897-904. PubMed PMID: 26313471.
  • Subaiya S, Dumolard L, Lydon P, Gacic-Dobo M, Eggers R, Conklin L. Global Routine Vaccination Coverage, 2014. MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1252-5. doi: 10.15585/mmwr.mm6444a5. PubMed PMID: 26562454.
  • Velandia-González M, Trumbo SP, Díaz-Ortega JL, Bravo-Alcántara P, Danovaro-Holliday MC, Dietz V, Ruiz-Matus C. Lessons learned from the development of a new methodology to assess missed opportunities for vaccination in Latin America and the Caribbean. BMC Int Health Hum Rights. 2015 Feb 21;15:5. doi: 10.1186/s12914-015-0043-1. PubMed PMID: 25889653; PubMed Central PMCID: PMC4357152.
  • Vinekar K, Schaad N, Ber Lucien MA, Leshem E, Oboho IK, Joseph G, Juin S, Dawood FS, Parashar U, Katz MA, Tohme RA. Hospitalizations and Deaths Because of Respiratory and Diarrheal Diseases Among Haitian Children Under Five Years of Age, 2011-2013. Pediatr Infect Dis J. 2015 Oct;34(10):e238-43. doi:10.1097/INF.0000000000000805. PubMed PMID: 26244833; PubMed Central PMCID: PMC4610905.
  •  Yen C, Hyde TB, Costa AJ, Fernandez K, Tam JS, Hugonnet S, Huvos AM, Duclos P, Dietz VJ, Burkholder BT. The development of global vaccine stockpiles. Lancet Infect Dis. 2015 Mar;15(3):340-7. doi: 10.1016/S1473-3099(14)70999-5. Epub 2015 Feb 6. Review. PubMed PMID: 25661473.

2014

  • DeRoeck D and Wang SA.  Principles and considerations for adding a vaccine into a national immunization programme: From decision to implementation and monitoring.  ISBN 978 92 4 150689 2.  World Health Organization, Geneva, Switzerland, April 2014.
  • Dunkle SE, Wallace AS, MacNeil A, Mustafa M, Gasasira A, Ali D, Elmousaad H, Mahoney F, Sandhu HS. Limitations of using administratively reported immunization data for monitoring routine immunization system performance in Nigeria. J Infect Dis. 2014 Nov 1;210 Suppl 1:S523-30. doi: 10.1093/infdis/jiu373. PubMed PMID: 25316876.
  • Gidado SO, Ohuabunwo C, Nguku PM, Ogbuanu IU, Waziri NE, Biya O, Wiesen ES, Mba-Jonas A, Vertefeuille J, Oyemakinde A, Nwanyanwu O, Lawal N, Mahmud M, Nasidi A, Mahoney FJ; N-STOP Outreach Team. Outreach to underserved communities in northern Nigeria, 2012-2013. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S118-24. doi: 10.1093/infdis/jiu197. PubMed PMID: 25316825.
  • Harris JB, Gacic-Dobo M, Eggers R, Brown DW, Sodha SV; Centers for Disease Control and Prevention (CDC). Global routine vaccination coverage, 2013. MMWR Morb Mortal Wkly Rep. 2014 Nov 21; 63(46):1055-8. PubMed PMID: 25412062.
  • Hennessey K, Schluter WW, Wang X, Boualam L, Jee Y, Mendoza-Aldana J, Roesel S, Diorditsa S, Ehrenberg J. Are we there yet? Assessing achievement of vaccine-preventable disease goals in WHO's Western Pacific Region. Vaccine. 2014 Jul 23; 32(34):4259-66. doi: 10.1016/j.vaccine.2014.02.093. Epub 2014 Jun 16. PubMed PMID: 24947995.
  • MacNeil A, Dietz V, Cherian T. Vaccine preventable diseases: time to re-examine global surveillance data? Vaccine. 2014 Apr 25; 32(20):2315-20. doi:10.1016/j.vaccine.2014.02.067. Epub 2014 Mar 11. PubMed PMID: 24625342.
  • MacNeil A, Lee CW, Dietz V. Issues and considerations in the use of serologic biomarkers for classifying vaccination history in household surveys. Vaccine. 2014 Sep 3; 32(39):4893-900. doi:  10.1016/j.vaccine.2014.07.005. Epub 2014 Jul 18. PubMed PMID: 25045821.
  • Murray J, Agócs M, Serhan F, Singh S, Deloria-Knoll M, O'Brien K, Mwenda JM, Mihigo R, Oliveira L, Teleb N, Ahmed H, Wasley A, Videbaek D, Wijesinghe P, Thapa AB, Fox K, Paladin FJ, Hajjeh R, Schwartz S, Beneden CV, Hyde T, Broome C, Cherian T. Global invasive bacterial vaccine-preventable diseases surveillance - 2008-2014. MMWR Morb Mortal Wkly Rep. 2014 Dec 12; 63(49):1159-62. PubMed PMID: 25503919.
  • Nyangoma EN, Arriola CS, Hagan JE, Socias C, Tomczyk S, Watkins LF, Westercamp M, Kim C. Hospitalizations for respiratory disease among unaccompanied children from Central America — Multiple States, June–July 2014(2014) MMWR, 63 (32),2014: pp. 698-699
  • Odone A, Ferrari A, Spagnoli F, Visciarelli S, Shefer A, Pasquarella C, Signorelli C. Effectiveness of interventions that apply new media to improve vaccine uptake and vaccine coverage. Hum Vaccin Immunother. 2014 Aug 7:e34313. [Epub ahead of print] PubMed PMID: 25483518.
  • Okayasu H, Brown AE, Nzioki MM, Gasasira AN, Takane M, Mkanda P, Wassilak SG, Sutter RW. Cluster lot quality assurance sampling: effect of increasing the number of clusters on classification precision and operational feasibility. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S341-6. doi: 10.1093/infdis/jiu162. PubMed PMID: 25316853.
  • Wallace AS, Mantel C, Mayers G, Mansoor O, Gindler JS, Hyde TB. Experiences with provider and parental attitudes and practices regarding the administration of multiple injections during infant vaccination visits: lessons for vaccine introduction. Vaccine. 2014 Sep 15; 32(41):5301-10. doi: 10.1016/j.vaccine.2014.07.076. Epub 2014 Aug 1. PubMed PMID: 25092632.
  • Wallace AS, Ryman TK, Dietz V. Overview of global, regional, and national routine vaccination coverage trends and growth patterns from 1980 to 2009: implications for vaccine-preventable disease eradication and elimination initiatives. J Infect Dis. 2014 Nov 1; 210 Suppl 1:S514-22. doi:10.1093/infdis/jiu108. PubMed PMID: 25316875.

Yellow Fever

2014

  • Kamadjeu R. Yellow card or red card: airport tribulations and new developments on yellow fever vaccination. Pan Afr Med J. 2014 Jan 26; 17:58. doi: 10.11604/pamj.2014.17.58.3907. eCollection 2014. PubMed PMID: 25018808; PubMed Central PMCID: PMC4085950.
  • Page last reviewed: August 4, 2016
  • Page last updated: August 4, 2016
  • Content source:

    Global Health
    Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site.

Top